Published in Cancer Weekly, September 16th, 1996
Dr. Rena Vassilopoulou-Sellin and Mary Jean Klein interviewed 137 women who met criteria for the study. They report that one-third of those women were apprehensive about the previously reported risks associated with hormone therapy.
Vassilopoulou-Sellin and colleague found that 17 percent of the women interviewed were willing to enroll in the study. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.